Skip to main content

Table 2 Prevalence of pathogens, pathogen-specific antigens and antibodies in the study population

From: Prevalence of pregnancy-relevant infections in a rural setting of Ghana

Pathogen

N

Serological assays

Direct proof

IgM

IgG

IgA

Current pregnancy-relevant infections

HBV a (HBsAg pos)

174

-

-

-

16·7%e

Plasmodium spp.b

180

-

-

-

+ 6·1%

++ 1·7%

+++ 2·8%

GBS c

180

-

-

-

10·6%

HCV

174

N/A

1·1%

N/A

-

HIV

173

0·6%*

0·6%*

0·6%*

-

C. trachomatis d

177

-

-

-

1·7%

HSV-1/−2

174

11·5%

100%

N/A

1·1%d

High susceptibility for potentially acquiring primary infection

VZV

169

n.d.

56·8%

2.4%

-

T. gondii

168

1·8%**

73·2%

n.d.

-

Parvovirus B19

170

4·7%

80·0%

N/A

-

Rubella virus

172

4·7%

84·3%

N/A

-

Past pregnancy-relevant infections

CMV

172

0%

100%

N/A

-

T. pallidum

180

0%+

2·8 / 5·0%++

N/A

-

Absence of pregnancy-relevant infections

N. gonorrhoeaec

180

-

-

-

0

Listeria spp.c

180

-

-

-

0

  1. Direct pathogen proof was carried out by antigen testa, microscopy and countingb, cultivationc, or PCRd . eFive out of 23 tested HBsAg positive women (21.7%) were also HBeAg positive. -: not applicable. N/A: not available, n.d.: not done. *the assay used does not discriminate between antibody and antigen, **IgM-positive samples with high IgG avidity, +VDRL, ++FTA-ABS/TPPA